Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What News Is Impacting Hercules Capital Htgc Stock Price At 14.90 Up 1.09 20260410 Westrock WEST Q1 2026 Earnings Miss by Significant Key Takeaways Crit Metals CRML Drops 457 Key Support at 1052 20260515 Indias Tax Administration Set for Major Overhaul to Ensure Smooth GST Rollout Surrozen SRZN Q3 2025 Earnings Miss Sparks Concern Wells WFC Gained 176 Can It Break 7965 20260520 SKK SKK Corrects 561 Key Support to Watch at 368 20260521 Charter Communications and Liberty Broadband Agree to Revised Buyout Deal with Enhanced Terms Universal ULH Q1 2026 Earnings Miss EPS 013 vs 009 Expected European Companies Maintain China Manufacturing Despite EU DeRisking Push GLOBALFOUNDRIES Inc Launches Quantum Technology Solutions A New Frontier in Semiconductor Manufacturing California Chemical Tank Leak Prompts Evacuations of Over 40000 Raises Safety Concerns Wingstop Shares Drop 12 as Profit Misses Market Expectations Indias Sebi Considers Uniform Disclosure Rules for Bonds Plans Tokenised Bond Market Pilot Nvidia Stock Declines PostEarnings Why Sellers May Be Overlooking Key Growth Drivers TE Q1 2026 Earnings NarrowerthanExpected Loss as Company Advances Strategic Initiatives Outdoor Holding Company POWW Q1 2026 Earnings A Surprising Profit Amid Challenging Conditions MBAI Q3 2023 Earnings WiderThanExpected Loss Weighs on Shares BOTJ Q1 2025 Earnings EPS of 019 Reported Stock Edges Higher PLRX Q1 2026 Earnings Narrowerthanexpected Loss Highlights Clinical Pipeline Progress CCAP Q1 2026 Earnings Narrow EPS Miss Amid Steady Portfolio Performance FSV Q1 2026 Earnings EPS Beats Estimates by 63 Amid Mixed Market Sentiment Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise DARE Q1 2026 Earnings EPS Surpasses Estimates as Net Loss Narrows AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances